Docetaxel vs non‐docetaxel‐containing regimens
Treatment discontinuation due to toxicity · people with advanced gastric cancer
Docetaxel showed no clear difference in treatment discontinuation due to toxicity compared with non‐docetaxel‐containing regimens (low certainty).
1 finding from 1 review
- OR 0.81 [0.53, 1.25]5 studies · 1066 participantsLow